Chronic Lameness: What the Research Says

Evidence from 19 peer-reviewed studies

2 RCT
5 Cohort Study
7 Case Report
5 Expert Opinion

What Professionals Should Know

  • If using flunixin meglumine for chronic lameness in horses, concurrent omeprazole administration (4 mg/kg PO q24h) significantly reduces gastric ulcer risk without compromising pain relief efficacy
  • Monitor horses on FM monotherapy closely for EGUS development, particularly Mongolian breeds, as lameness improvement masks ongoing gastric damage
  • The combination FM+OME is a practical gastroprotective strategy for working horses requiring extended NSAID therapy for pain management
  • Firocoxib at 0.1 mg/kg once daily is the effective dose for treating chronic osteoarthritis-related lameness in horses, with measurable improvements within 2-6 days of treatment
  • Force plate measurements provide objective evidence of lameness improvement that may not be apparent on clinical grading alone, useful for evaluating treatment response
  • Higher doses (0.25 mg/kg) offer no additional benefit over the 0.1 mg/kg dose, suggesting dose optimization can reduce costs without sacrificing efficacy
  • Acetaminophen at 30 mg/kg twice daily is safe for 21 days with no hepatic or gastric toxicity concerns in chronic lameness cases
  • Short-term subjective improvement occurs within 2-4 hours post-dose, but this transient effect suggests acetaminophen alone is insufficient for managing chronic lameness
  • Consider acetaminophen as an adjunctive rather than standalone therapy, combining with other pain management strategies for better clinical outcomes
  • COP pathway analysis offers an objective measurement tool for detecting and monitoring chronic lameness in horses with osteoarthritis beyond traditional visual assessment
  • Understanding how pain alters pressure distribution during stance phase can inform farriery decisions and therapeutic interventions
  • This biomechanical approach may help identify subtle lameness early before structural damage progresses
  • Use wearable sensor technology to objectively monitor recumbency patterns in individual horses; very low lying times (<8 min/day) warrant investigation for pain, anxiety, or environmental factors limiting sleep
  • Chronic lameness and advanced age alone do not necessarily reduce lying behaviour, but horses with truly low recumbency require urgent assessment as this indicates serious welfare compromise and REM sleep deficit
  • Integrate recumbency monitoring into welfare assessments for geriatric and chronically lame horses to identify those at risk before clinical signs of sleep deprivation manifest
  • This COMP neoepitope biomarker may enable detection of early cartilage damage before structural lesions appear on imaging, potentially allowing earlier intervention in lame horses
  • A synovial fluid test based on this biomarker could help differentiate acute cartilage injury from chronic OA, informing prognosis and treatment decisions
  • Further validation in clinical populations is needed before this assay can be adopted as a routine diagnostic tool in practice
  • RPWT combined with structured exercise is a viable treatment option for chronic or recurrent suspensory desmitis, with over 40% of cases returning to full work within 6 months
  • Ultrasonographic assessment at diagnosis helps predict outcome—more severe lesions carry poorer prognosis, so realistic expectations should be set with owners early
  • Hindlimb PSD appears to benefit more from RPWT than forelimb cases based on this data, which may influence treatment recommendations
  • NEM supplementation at 12 mg/kg appears well-tolerated and horses readily accept it, making compliance easier than some joint supplements
  • Riders reported noticeable functional improvements in ridden work within 12 weeks, though objective lameness examination improvements were modest
  • This shows promise for chronic lameness management but should be viewed as a potential complementary approach rather than a primary treatment until larger controlled trials confirm efficacy
  • CFJOA should be suspected in older horses (median age 14 years) with chronic unilateral lameness, gluteal atrophy, and altered gait mechanics (three-track locomotion, stride lengthening)
  • Ventrodorsal radiographs are the gold standard for diagnosis and should be routinely obtained when CFJOA is suspected; the new standardised radiographic score facilitates consistent assessment and documentation
  • Medical management with intra-articular corticosteroids has poor long-term outcomes; postmortem evidence of ligamentous rupture suggests joint instability is a driving factor, explaining resistance to conservative therapy and potentially guiding future treatment strategies
  • Multicentric lymphoma should be included in differential diagnoses for geriatric donkeys with chronic lameness, laminitis, and systemic signs of disease, even though it is rare in this species
  • Post-mortem examination with histopathology and immunohistochemistry is necessary to definitively diagnose lymphoma and characterize T-cell versus B-cell phenotype
  • Further research is needed to understand why donkeys appear naturally resistant to lymphoma development compared to horses, which may have implications for preventive strategies
  • Persistent or recurrent hoof masses in horses require careful monitoring and repeat histopathological examination, as benign lesions may progress to malignancy over time
  • Do not assume melanoma is unlikely in non-gray horses; maintain clinical suspicion for malignant transformation regardless of coat color
  • Multiple surgical resections with sequential histopathology may be necessary to establish final diagnosis and detect progression from benign to malignant disease
  • Subchondral cyst-like lesions of the middle phalanx are rare but should be considered in cases of chronic distal interphalangeal joint lameness unresponsive to medical management.
  • Advanced imaging is essential for diagnosis and surgical planning of these lesions.
  • Surgical debridement with biologic augmentation using bone marrow aspirate and platelet-rich plasma may be effective when conservative management fails.
  • Deep branch lateral palmar nerve neurectomy is a viable surgical option for chronic proximal suspensory desmitis cases that fail conservative therapy, with excellent short and medium-term outcomes
  • Pain localization via regional anesthesia should guide surgical decision-making in these cases
  • This procedure may restore functional soundness in sport horses where conservative management has proven ineffective
  • Any chronic hoof wall mass with lameness warrants biopsy and histologic examination, even if radiographic appearance suggests benign keratoma—do not assume benign based on imaging alone.
  • Squamous cell carcinoma of the hoof can progress rapidly to involve articular structures; early accurate diagnosis improves treatment planning and prognosis discussion with owners.
  • Farriers and veterinarians should maintain a high index of suspicion for malignancy when presented with non-sensitive hoof wall masses and chronic unexplained lameness, and refer for tissue diagnosis promptly.
  • Ultrasound-guided radiofrequency ablation of palmar digital nerves is technically feasible in horses and produces reproducible thermal damage to target nerves, offering a potential new pain management tool for chronic forelimb lameness.
  • Accurate needle positioning very close to the target nerve is critical for treatment success; the pastern location appears more accessible than the fetlock using this technique.
  • This cadaveric proof-of-concept supports progressing to clinical trials, but practitioners should await in vivo safety and efficacy data before considering this technique for chronic lameness cases.
  • While PBZ is standard for lameness management, concurrent omeprazole use for EGUS prevention is common practice but lacks evidence in Mongolian horses specifically
  • Veterinarians should await results of this study before modifying protocols for combined PBZ-OME therapy in this population
  • Consider gastric ulcer risk as a significant consideration when prescribing phenylbutazone for chronic lameness cases
  • Rider position and horse posture directly influence loading patterns through the spine and limbs; assess neck flexion and stride symmetry in lame horses as these correlate with cervical degeneration sites
  • A horse showing asymmetric stride with dorsiflexion of lower limbs may be compensating for cervical pain or restriction—postural correction through riding adjustments could be therapeutically relevant
  • This tool shows promise for objectively linking specific postural abnormalities to degeneration sites, potentially enabling earlier intervention before pathology becomes severe
  • Artificial limb length changes via orthotic lifts produce measurable, consistent pelvic biomechanical adaptations within single trotting sessions—consider this when correcting hoof imbalances or chronic lameness with uneven foot wear
  • The lack of consistent head/withers compensation despite clear pelvic changes suggests horses may prioritize pelvic stability over upper body symmetry when managing limb length differences
  • Orthotic interventions for horses with chronic lameness or contralateral hoof shape asymmetry should account for immediate pelvic movement redistribution as a positive weight-management strategy
  • Managing navicular disease should focus on reducing forelimb overload and preventing habitual dorsiflexion through farrier and training modifications
  • Understanding that navicular lesions result from biomechanical overload rather than primary bone pathology supports conservative, load-management approaches over invasive interventions
  • Rehabilitation protocols should aim to restore normal foot mechanics and weight distribution to reduce chronic stress on the navicular apparatus

Key Research Findings

Flunixin meglumine (FM) alone significantly increased EGGD grade (3.0 vs 0.0 in controls, p<0.001) and pepsinogen 1 levels (372.2±33.2 ng/mL vs 231.9±25.2 ng/mL, p<0.001) despite effectively reducing lameness scores

Guo, 2025

FM combined with omeprazole (FM+OME) reduced lameness equally to FM alone but significantly decreased EGGD grade (0.8 vs 3.0, p=0.003) and increased gastric pH (7.4±0.2 vs 2.4±0.3, p<0.001)

Guo, 2025

FM alone reduced serum total protein, albumin, and gastrin-17 levels compared to controls, suggesting systemic effects beyond gastric damage

Guo, 2025

Histopathological examination confirmed FM-induced gastric lesions in Mongolian horses that were mitigated by concurrent omeprazole administration

Guo, 2025

Firocoxib at 0.1 mg/kg bwt once daily significantly improved peak vertical force (PVF) measurements at Days 2 and 6 compared to vehicle control (P < 0.05)

Back W, 2009

Mean clinical lameness grades decreased by >1 grade at Day 6 with both 0.1 and 0.25 mg/kg bwt doses

Back W, 2009

The 0.1 mg/kg bwt dose was as effective as the 0.25 mg/kg bwt dose, making it the optimal therapeutic dosage

Back W, 2009

Force plate analysis of peak vertical force proved superior to lameness grading alone for detecting drug efficacy

Back W, 2009

Acetaminophen 30 mg/kg PO every 12 h achieved Cmax of 20.83 ± 10.25 μg/mL on day 7 with Tmax of 0.40 ± 0.22 h

Mercer Melissa A, 2024

Subjective lameness scores significantly improved at 2 and 4 h post-treatment, with significant PDmax improvement in hindlimb lameness at 1, 2, and 8 h post-treatment

Mercer Melissa A, 2024

No clinically significant changes detected in clinicopathological analysis, hepatic biopsy, or gastric ulceration scores following 21 days of treatment

Mercer Melissa A, 2024

Acetaminophen produced only transient improvement and may not be effective as monotherapy for chronic lameness

Mercer Melissa A, 2024

Centre of pressure (COP) pathway analysis can characterize gait patterns in horses with chronic osteoarthritic pain

Buser Larissa Irina, 2023

COP trajectory from footstrike to lift-off differs between lame and sound horses

Buser Larissa Irina, 2023

COP path metrics provide quantifiable biomechanical indicators of lameness severity

Buser Larissa Irina, 2023

Evidence Base

Assessing omeprazole and flunixin meglumine co-administration in treating equine gastric ulcer syndrome in Mongolian horses.

Guo, Li, Mao et al. (2025)Equine veterinary journal

RCT

The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.

Back W, MacAllister C G, van Heel M C V et al. (2009)Equine veterinary journal

RCT

Pharmacokinetics, clinical efficacy and safety of acetaminophen (paracetamol) in adult horses with naturally occurring chronic lameness.

Mercer Melissa A, Davis Jennifer L, McKenzie Harold C et al. (2024)Equine veterinary journal

Cohort Study

Evaluation of the hoof centre-of-pressure path in horses affected by chronic osteoarthritic pain.

Buser Larissa Irina, Torelli Nathan, Andreis Sabrina et al. (2023)PloS one

Cohort Study

Recumbency as an Equine Welfare Indicator in Geriatric Horses and Horses with Chronic Orthopaedic Disease.

Kelemen Zsofia, Grimm Herwig, Long Mariessa et al. (2021)Animals : an open access journal from MDPI

Cohort Study

Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis.

Ski&#xf6;ldebrand E, Ekman S, Mattsson Hult&#xe9;n L et al. (2017)Equine veterinary journal

Cohort Study

Treatment of chronic or recurrent proximal suspensory desmitis using radial pressure wave therapy in the horse.

Crowe O M, Dyson S J, Wright I M et al. (2004)Equine veterinary journal

Cohort Study

Natural eggshell membrane supplementation for chronic lameness in warmblood horses: a 12-week prospective before-after study.

Kwon Young-Sam, Jeong Hyohoon, Kim Jongkyu et al. (2026)Frontiers in veterinary science

Case Report

Osteoarthritis of the coxofemoral joint in 24 horses: Evaluation of radiography, ultrasonography, intra-articular anaesthesia, treatment and outcome.

Sauer Fay J, Hellige Maren, Beineke Andreas et al. (2025)Equine veterinary journal

Case Report

Multicentric lymphoma in a donkey with intestinal and bone marrow involvement.

Paraschou Georgios, Xue Cynthia, Egan Rebecca et al. (2024)BMC veterinary research

Case Report

From Keratoma to Anaplastic Malignant Melanoma in a Horse's Hoof.

Stefanik El&#x17c;bieta, G&#xf3;rski Kamil, Turek Bernard et al. (2022)Animals : an open access journal from MDPI

Case Report

Surgical Treatment of an Osseous Cyst-Like Lesion in the Middle Phalanx Communicating With the Distal Interphalangeal Joint of a Horse.

Balducci Jamie J, Barrett Myra F, Moorman Valerie J (2019)Journal of equine veterinary science

Case Report

Excision of the deep branch of the lateral palmar nerve of horses to resolve lameness caused by proximal suspensory desmitis.

Guasco Paolo Gay, Kelly Ger, Schumacher James et al. (2013)Veterinary surgery : VS

Case Report

Squamous cell carcinoma of the hoof wall in a stallion.

Berry, O'Brien, Pool (1991)Journal of the American Veterinary Medical Association

Case Report

Development of an ultrasound-guided radiofrequency ablation technique in the equine cadaveric distal limb: histological findings and potential for treating chronic lameness.

Amari Martina, Rabbogliatti Vanessa, Ravasio Giuliano et al. (2024)Frontiers in veterinary science

Expert Opinion

Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses.

Li Zhengyi, Du Shan, Wang Xiaomin et al. (2024)Equine veterinary journal

Expert Opinion

The Horse & Rider: A Dynamic 3D Model for Studying the Role of Chronic Postural Asymmetries in Degenerative Osteoarthritis

Alexander K. K. Lee, E. Uhl, Michelle L. Osborn (2020)The FASEB Journal

Expert Opinion

Effect of a unilateral hind limb orthotic lift on upper body movement symmetry in the trotting horse.

Vertz, Deblanc, Rhodin et al. (2019)PloS one

Expert Opinion

Analysis of Forces Acting on the Equine Navicular Bone in Normal and Dorsiflexed Positions

Kaitlyn C Ruff, Michelle L. Osborn, E. Uhl (2016)The FASEB Journal

Expert Opinion